Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00BVJ
|
|||
| Former ID |
DIB006728
|
|||
| Drug Name |
NHS-IL 12
|
|||
| Synonyms |
NHS-IL12
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Emd serono; national cancer institute
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01417546) NHS-IL12 for Solid Tumors. U.S. National Institutes of Health. | |||
| REF 2 | The immunocytokine NHS-IL12 as a potential cancer therapeutic. Oncotarget. 2014 Apr 15;5(7):1869-84. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.